Novavax, Inc. (NVAX) Prices Offering Of Common Stock
Novavax, Inc. priced an offering of common stock at $3.30 per share. The company is offering 6.8 million shares and estimates that net proceeds to the company will be $21 million after underwriting expenses and other costs. Piper Jaffray & Co. and Lazard Capital Markets LLC are underwriting the offering, and can offer an additional 1.02 million shares to cover over allotments if needed. Novavax, Inc. is an early stage biotechnology company that is focused on vaccines that use virus like particle technology. The virus like particle technology is proprietary to Novavax, Inc., and involves the creation of vaccines that…